InsidersTradesSigma
Declaraciones totales
Empresas
▲ Compras (0 oper.)
▼ Ventas (55 oper.)
Historial del iniciado
ConsejeroCompras declaradas
0
Ventas declaradas
55
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the complete record of transactions filed by MPM BioVentures 2014, L.P., Board Member / Venture Capital Investor. Director active across 5 companies, notably Werewolf Therapeutics, Inc.. Cumulatively, 63 reports have been published. Split: 0 buy · 55 sells. Total volume traded: €30.6m. Activity tracked since 7 September 2021. The latest transaction was disclosed on 28 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to MPM BioVentures 2014, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones63 en total
3733 títulos@ 7,01 US$Common StockSEC:0001231919-26-001135:1
3733 títulos@ 7,01 US$Common StockSEC:0001231919-26-001136:1
44.259 títulos@ 6,99 US$Common StockSEC:0001231919-26-001135:2
44.259 títulos@ 6,99 US$Common StockSEC:0001231919-26-001136:2
38.922 títulos@ 7,20 US$Common StockSEC:0001231919-26-001136:0
38.922 títulos@ 7,20 US$Common StockSEC:0001231919-26-001135:0
21.623 títulos@ 7,34 US$0.056% mcap16.0% de su flujoCommon StockSEC:0001231919-26-001106:0
26.522 títulos@ 7,54 US$0.070% mcap20.2% de su flujoCommon StockSEC:0001231919-26-001107:1
14.569 títulos@ 7,06 US$0.036% mcap10.4% de su flujoCommon StockSEC:0001231919-26-001106:2
14.569 títulos@ 7,06 US$0.036% mcap10.4% de su flujoCommon StockSEC:0001231919-26-001107:2
26.522 títulos@ 7,54 US$0.070% mcap20.2% de su flujoCommon StockSEC:0001231919-26-001106:1
21.623 títulos@ 7,34 US$0.056% mcap16.0% de su flujoCommon StockSEC:0001231919-26-001107:0
1.314.262 títulosCommon StockSEC:0001231919-26-000057:0
59.277 títulos@ 0,89 US$6.3% de su flujoCommon StockSEC:0001231919-25-000575:0
60.733 títulos@ 0,98 US$7.6% de su flujoCommon StockSEC:0001231919-25-000565:0
64.331 títulos@ 0,83 US$7.4% de su flujoCommon StockSEC:0001231919-25-000551:0
52.627 títulos@ 0,93 US$7.3% de su flujoCommon StockSEC:0001231919-25-000534:0
90.951 títulos@ 0,98 US$14.3% de su flujoCommon StockSEC:0001231919-25-000509:0
68.480 títulos@ 1,11 US$14.3% de su flujoCommon StockSEC:0001231919-25-000461:0
140.488 títulos@ 1,22 US$37.7% de su flujoCommon StockSEC:0001231919-25-000441:0
86.936 títulos@ 1,43 US$43.7% de su flujoCommon StockSEC:0001231919-25-000406:0
72.709 títulos@ 1,72 US$77.8% de su flujoCommon StockSEC:0001231919-25-000374:0
630.191 títulos@ 8,06 US$20.0% de su flujoCommon StockSEC:0001415889-25-013251:0
630.191 títulos@ 8,06 US$20.0% de su flujoCommon StockSEC:0001415889-25-013248:0
22.758 títulos@ 0,09 US$100.0% de su flujoCommon StockSEC:0001415889-25-011574:0
25 de 63 declaraciones
About MPM BioVentures 2014, L.P.
MPM BioVentures 2014, L.P. is a Board Member / Venture Capital Investor. The record shows 31 filings in total, and the 31 sampled filings between 2021-05-06 and 2025-12-04 show only sales, with EUR 14738753 in sells and EUR 0 in buys. The companies involved include iTeos Therapeutics, Inc., Werewolf Therapeutics, Inc., Entrada Therapeutics, Inc., and TCR2 THERAPEUTICS INC.
